位置:首页 > 蛋白库 > TOB1A_XENLA
TOB1A_XENLA
ID   TOB1A_XENLA             Reviewed;        1513 AA.
AC   Q800K6; B7ZSK6;
DT   10-AUG-2010, integrated into UniProtKB/Swiss-Prot.
DT   10-AUG-2010, sequence version 2.
DT   03-AUG-2022, entry version 91.
DE   RecName: Full=DNA topoisomerase 2-binding protein 1-A;
DE   AltName: Full=Cut5 protein {ECO:0000303|PubMed:12743046};
DE   AltName: Full=DNA topoisomerase II-binding protein 1-A;
DE            Short=TopBP1-A;
DE            Short=XtopBP {ECO:0000303|PubMed:16530042};
GN   Name=topbp1-A; Synonyms=cut5 {ECO:0000312|EMBL:BAC65235.1};
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC   Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX   NCBI_TaxID=8355;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:BAC65235.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH CDC45, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Oocyte {ECO:0000269|PubMed:12743046};
RX   PubMed=12743046; DOI=10.1093/emboj/cdg238;
RA   Hashimoto Y., Takisawa H.;
RT   "Xenopus Cut5 is essential for a CDK-dependent process in the initiation of
RT   DNA replication.";
RL   EMBO J. 22:2526-2535(2003).
RN   [2] {ECO:0000312|EMBL:AAI70556.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Oocyte {ECO:0000312|EMBL:AAI70556.1};
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (NOV-2008) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=12730133; DOI=10.1101/gad.1070003;
RA   Kubota Y., Takase Y., Komori Y., Hashimoto Y., Arata T., Kamimura Y.,
RA   Araki H., Takisawa H.;
RT   "A novel ring-like complex of Xenopus proteins essential for the initiation
RT   of DNA replication.";
RL   Genes Dev. 17:1141-1152(2003).
RN   [4] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=14525986; DOI=10.1074/jbc.c300418200;
RA   Parrilla-Castellar E.R., Karnitz L.M.;
RT   "Cut5 is required for the binding of Atr and DNA polymerase alpha to
RT   genotoxin-damaged chromatin.";
RL   J. Biol. Chem. 278:45507-45511(2003).
RN   [5] {ECO:0000305}
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15960976; DOI=10.1016/j.cell.2005.05.015;
RA   Sangrithi M.N., Bernal J.A., Madine M., Philpott A., Lee J., Dunphy W.G.,
RA   Venkitaraman A.R.;
RT   "Initiation of DNA replication requires the RECQL4 protein mutated in
RT   Rothmund-Thomson syndrome.";
RL   Cell 121:887-898(2005).
RN   [6] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH ATR, AND MUTAGENESIS OF TRP-1138.
RX   PubMed=16530042; DOI=10.1016/j.cell.2005.12.041;
RA   Kumagai A., Lee J., Yoo H.Y., Dunphy W.G.;
RT   "TopBP1 activates the ATR-ATRIP complex.";
RL   Cell 124:943-955(2006).
RN   [7] {ECO:0000305}
RP   FUNCTION, DOMAIN, PHOSPHORYLATION AT SER-1131, AND MUTAGENESIS OF SER-1131.
RX   PubMed=16923121; DOI=10.1111/j.1365-2443.2006.00998.x;
RA   Hashimoto Y., Tsujimura T., Sugino A., Takisawa H.;
RT   "The phosphorylated C-terminal domain of Xenopus Cut5 directly mediates
RT   ATR-dependent activation of Chk1.";
RL   Genes Cells 11:993-1007(2006).
RN   [8] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=16436514; DOI=10.1091/mbc.e05-09-0865;
RA   Lupardus P.J., Cimprich K.A.;
RT   "Phosphorylation of Xenopus Rad1 and Hus1 defines a readout for ATR
RT   activation that is independent of Claspin and the Rad9 carboxy terminus.";
RL   Mol. Biol. Cell 17:1559-1569(2006).
RN   [9] {ECO:0000305}
RP   INTERACTION WITH RECQL4, AND SUBCELLULAR LOCATION.
RX   PubMed=16782873; DOI=10.1128/mcb.02267-05;
RA   Matsuno K., Kumano M., Kubota Y., Hashimoto Y., Takisawa H.;
RT   "The N-terminal noncatalytic region of Xenopus RecQ4 is required for
RT   chromatin binding of DNA polymerase alpha in the initiation of DNA
RT   replication.";
RL   Mol. Cell. Biol. 26:4843-4852(2006).
RN   [10] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH TICRR, AND SUBCELLULAR LOCATION.
RX   PubMed=20116089; DOI=10.1016/j.cell.2009.12.049;
RA   Kumagai A., Shevchenko A., Shevchenko A., Dunphy W.G.;
RT   "Treslin collaborates with TopBP1 in triggering the initiation of DNA
RT   replication.";
RL   Cell 140:349-359(2010).
RN   [11] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH GEMC1.
RX   PubMed=20383140; DOI=10.1038/ncb2050;
RA   Balestrini A., Cosentino C., Errico A., Garner E., Costanzo V.;
RT   "GEMC1 is a TopBP1-interacting protein required for chromosomal DNA
RT   replication.";
RL   Nat. Cell Biol. 12:484-491(2010).
CC   -!- FUNCTION: Has dual roles in initiation of DNA replication, and
CC       regulation of checkpoint responses. Required for DNA replication
CC       initiation but not for the formation of pre-replicative complexes or
CC       the elongation stages. Necessary for the loading of replication factors
CC       onto chromatin, including gemc1, cdc45, DNA polymerases and components
CC       of the GINS complex such as ginsl/sld5. Binds chromatin in both S-phase
CC       cyclin-dependent kinase (S-CDK)-independent and S-CDK-dependent modes.
CC       Chromatin binding is required for the action of S-CDK, which in turn
CC       triggers the formation of preinitiation complexes of DNA replication.
CC       Its role in checkpoint activation is independent of the DNA replication
CC       role. In response to DNA damage, triggers the recruitment of checkpoint
CC       signaling proteins on chromatin, which activate the chek1 signaling
CC       pathway and block S-phase progression. Increases the kinase activity of
CC       atr to numerous substrates, and is required for the phosphorylation of
CC       Rad1. {ECO:0000269|PubMed:12730133, ECO:0000269|PubMed:12743046,
CC       ECO:0000269|PubMed:14525986, ECO:0000269|PubMed:15960976,
CC       ECO:0000269|PubMed:16436514, ECO:0000269|PubMed:16530042,
CC       ECO:0000269|PubMed:16923121, ECO:0000269|PubMed:20116089,
CC       ECO:0000269|PubMed:20383140}.
CC   -!- SUBUNIT: Interacts with cdc45. Interacts (via BRCT domains) with ticrr;
CC       interaction is cdk2-dependent. Interacts with atr in the presence of
CC       atrip. Interacts with recql4 (via N-terminus).
CC       {ECO:0000269|PubMed:12743046, ECO:0000269|PubMed:16530042,
CC       ECO:0000269|PubMed:16782873, ECO:0000269|PubMed:20116089,
CC       ECO:0000269|PubMed:20383140}.
CC   -!- INTERACTION:
CC       Q800K6; D3IUT5: ticrr; NbExp=4; IntAct=EBI-2607374, EBI-2607396;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12743046,
CC       ECO:0000269|PubMed:15960976, ECO:0000269|PubMed:16782873,
CC       ECO:0000269|PubMed:20116089}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000250}. Cytoplasm, cytoskeleton,
CC       spindle pole {ECO:0000250}. Chromosome {ECO:0000250}. Note=Associates
CC       with chromatin. {ECO:0000269|PubMed:12743046,
CC       ECO:0000269|PubMed:15960976, ECO:0000269|PubMed:16782873,
CC       ECO:0000269|PubMed:20116089}.
CC   -!- DOMAIN: The N-terminal half is sufficient for DNA replication.
CC       {ECO:0000269|PubMed:16923121}.
CC   -!- PTM: Phosphorylation at 1131 is essential for phosphorylation of chek1,
CC       and thus for checkpoint regulation. {ECO:0000269|PubMed:16923121}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB091779; BAC65235.1; -; mRNA.
DR   EMBL; BC170556; AAI70556.1; -; mRNA.
DR   EMBL; BC170557; AAI70557.1; -; mRNA.
DR   RefSeq; NP_001082568.1; NM_001089099.1.
DR   AlphaFoldDB; Q800K6; -.
DR   SMR; Q800K6; -.
DR   BioGRID; 99905; 6.
DR   IntAct; Q800K6; 2.
DR   iPTMnet; Q800K6; -.
DR   GeneID; 398573; -.
DR   KEGG; xla:398573; -.
DR   CTD; 398573; -.
DR   Xenbase; XB-GENE-990641; topbp1.L.
DR   Proteomes; UP000186698; Chromosome 6L.
DR   Bgee; 398573; Expressed in egg cell and 19 other tissues.
DR   GO; GO:0000785; C:chromatin; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000922; C:spindle pole; IEA:UniProtKB-SubCell.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0000076; P:DNA replication checkpoint signaling; IMP:UniProtKB.
DR   GO; GO:0006270; P:DNA replication initiation; IMP:UniProtKB.
DR   GO; GO:0071163; P:DNA replication preinitiation complex assembly; IMP:UniProtKB.
DR   GO; GO:0071165; P:GINS complex assembly; IMP:UniProtKB.
DR   GO; GO:0035563; P:positive regulation of chromatin binding; IMP:UniProtKB.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0071168; P:protein localization to chromatin; IMP:UniProtKB.
DR   GO; GO:0030174; P:regulation of DNA-templated DNA replication initiation; IMP:UniProtKB.
DR   CDD; cd17737; BRCT_TopBP1_rpt1; 1.
DR   Gene3D; 3.40.50.10190; -; 9.
DR   InterPro; IPR001357; BRCT_dom.
DR   InterPro; IPR036420; BRCT_dom_sf.
DR   InterPro; IPR035960; Secretoglobin_sf.
DR   InterPro; IPR044737; TopBP1_BRCT_1.
DR   Pfam; PF00533; BRCT; 4.
DR   Pfam; PF12738; PTCB-BRCT; 2.
DR   SMART; SM00292; BRCT; 9.
DR   SUPFAM; SSF48201; SSF48201; 1.
DR   SUPFAM; SSF52113; SSF52113; 6.
DR   PROSITE; PS50172; BRCT; 7.
PE   1: Evidence at protein level;
KW   Cell cycle; Chromosome; Cytoplasm; Cytoskeleton; DNA damage; DNA repair;
KW   DNA replication; DNA-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Repeat.
FT   CHAIN           1..1513
FT                   /note="DNA topoisomerase 2-binding protein 1-A"
FT                   /id="PRO_0000397210"
FT   DOMAIN          101..189
FT                   /note="BRCT 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   DOMAIN          194..283
FT                   /note="BRCT 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   DOMAIN          354..444
FT                   /note="BRCT 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   DOMAIN          530..621
FT                   /note="BRCT 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   DOMAIN          629..726
FT                   /note="BRCT 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   DOMAIN          892..984
FT                   /note="BRCT 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   DOMAIN          1253..1344
FT                   /note="BRCT 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   DOMAIN          1383..1480
FT                   /note="BRCT 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   REGION          289..308
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          789..809
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1031..1053
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1086..1109
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           844..850
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   MOTIF           1508..1511
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        789..803
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1131
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:16923121"
FT   MUTAGEN         1131
FT                   /note="S->A: Prevents phosphorylation. Prevents role in
FT                   checkpoint activation."
FT                   /evidence="ECO:0000269|PubMed:16923121"
FT   MUTAGEN         1131
FT                   /note="S->E: Phosphomimic. Exhibits minor defects in
FT                   checkpoint activation."
FT                   /evidence="ECO:0000269|PubMed:16923121"
FT   MUTAGEN         1138
FT                   /note="W->R: Abolishes activation of kinase activity of atr
FT                   but no effect on atr binding. Defective in checkpoint
FT                   regulation. No effect on DNA replication."
FT                   /evidence="ECO:0000269|PubMed:16530042"
FT   CONFLICT        309
FT                   /note="T -> A (in Ref. 1; BAC65235)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        472
FT                   /note="D -> G (in Ref. 1; BAC65235)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1188
FT                   /note="T -> S (in Ref. 1; BAC65235)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1347
FT                   /note="M -> I (in Ref. 1; BAC65235)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1513 AA;  169288 MW;  31BB4CB37DEF225B CRC64;
     MASSENEPFC VKFIKSPENS EYFFKAYEAI KQIQSDESLQ LTEEREALLL KEKDKSLYIC
     DPFSGAAFSH LKKLGCRIVG PQVVIFCMEN QRRVPRAEYP VYNMAMADVT ISCTSLDKET
     REDVHHYVQI MGGCVYRDLN VSVTHLIAGE VGSKKYLVAA SLEKPILLPS WVKELWEKSN
     QRIIRYSDVN MTEYLCPIFR GCTICVTGLS SLDRKEVQRL TALHGGEYTG QLKMNESTHL
     IVQEAKGQKY ECARKWNVHC ISVQWFFDSI EKGFCQDETM YKIEPASTIK SVPDTSTPTG
     GNSKPNSRTL YDVSQISNIS TSCVNESAFN SAMASRLDPP ADTLENLDIS SLQAPDDLLD
     GCRIYLCGFG GRKLDKLRKL INNGGGVRFN QLTGDVTHII VGETDEELKQ FLNKTQHRPY
     VLTVKWLLDS FAKGHLQPEE IYFHSSYQQT EMPSPFEPAI NLTANKMSST RDPLNHTRNH
     QADEDLLSQY TENNSTLIED EHPKTSNTNS ISQMSMHEDM TTCTSQSGLA DTSTIIEGGL
     FSRKQFMVLG FLEEDEACII DIIKKSAGKV LSSQKRAIAD YAVVPLLGCE VESTVGEVVT
     NAWLGMCIEQ EKLLDPHSNA LFTPVPFLEG STPLRECVLS VSQFMGAERD SLVYLAGLLG
     AKVQEFFVRK ANPKKGMFAS THLVLKDAEG SKYEAAKKWN LPAVTMNWLL QCARTGRKAD
     EDSYLVDNVP EEDKDESFIS QTYKPQAIRL SMHAPCHLEN HPEALTKAAV TPLDMNRFKS
     KAFQSVISQH NKNPQTSGGE SKVLQREPSL HLDTPSKFLS KDKLFKPSFD VKDALAALET
     PGGPNQKNRT QSTPLSEVIG RNLQLAIANS TRQTAAVTAS PQLKAAEKKE FDNSKLLINV
     VICVSKKLIK KQGELNGIAA SLGAEYRWCF DESVTHFIYH GRQNDMSREY KSVKERSGIY
     IVSEHWLFAC SEQQKRVPEA LYPHTYNPKM SLDISAVQDG SYTASKFSAD TSLQQDENSE
     LQLQQNNKFG ETSDDQVKKA AGDGNPQNPS KDVKGALTQT LEMRENFQRQ LQEFMSATSV
     VKPRGSVGRA GFDNSPCTPE GARSTRNGRS RVLEALRQSR QAMTDLNTEP SQNEQIIWDD
     PTAREERAKL VSNLQWPDSP SQYSEQLQHN MNDAGGNYTP AKESLTDTEI AELEACEFEP
     KSAMRTPVIE NNLQSPTKPD HLTPTPQAPS IAFPLANPPV APQPREKPVQ PFSKEETLKE
     RRFQLSSLDP QERIDYSQLI EELGGVVIEK QCFDPSCTHI VVGHPLRNEK YLASMAAGKW
     VLHRSYLEAC RAAKRFIQEE DYEWGSMSIL SAVTNINPQQ RMLAEAAMRW RKKLQGIKQN
     MGIAEGAFSG WKVILNVDQT KEPGFKRLLQ SGGAKVFAGH SSPLFKEASH LFADFSKLKP
     DEPRVNVAEA AAQGVNCLKP EYIADYLMKE LPPPMNNYCL PDAIPYVRVT GTGLSRKRKT
     SGDVSDVKRS RHY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025